C ancer stem cells (CSCs) are characterized by self-proliferation, an ability for symmetric/ asymmetric division and an ability to propagate cancer in vivo. Contrary to our expectation, CSCs show a quiescent nature, the morphology of small resting cells, resistance to multiple drugs/radiation, and side-population phenotypes distinct from major cancer cells. Research has been focused on overcoming drug resistance, discovery of biomarkers for CSCs, and tailored treatment targeting CSCs. Recently changing concepts of CSCs reflect the genetic heterogeneity, hierarchy of cancer tissue, and evolving dynamic mutations within one tumor. First, multiple CSC clones with different mutations including initiating driver mutations can coexist within one tumor. Second, CSCs stand at the top of the tumor hierarchy during therapy or disease progression, and the proportions of these clones are changing dynamically, depending on the cancer progression. Third, tailored treatments should be not fixed, according to the initial situation at diagnosis, but appropriate treatment should be attempted in accordance with the dynamic properties of CSCs at each stage of cancer.
Studies reporting the existence of enriched human CSC populations are listed. In the first five columns, the main parameters influencing the efficiency of tumor engraft-ment are listed. From left to right: the tumor entity, the type of immunocompromised mouse strain used, the route of transplantation of human tumor cells, precondition-ing of the recipient mice, treatment of mice during the assay, and whether the tumor cells were mixed with Matrigel upon transplantation. In the next four columns, the main results of these studies are summarized. From left to right: the frequency of the identified CSC-enriched population observed in the given tumor entity, the biomarkers identified for this CSC-enriched population, and the minimal number of tumor cells expressing these biomarkers able to give rise to a human tumor as well as the reference of the corresponding study. 
From

줄기세포 미세환경
종양의 미세환경은 다양한 면역세포와 기질세포, 그리고 
